Trade Desk Tops Estimates as Q1 Guidance Dims Outlook
Trade Desk beat Q4 expectations but issued softer Q1 guidance, sparking a swift market reaction as investors weigh sl...
Understand when to choose long term vs short term investments. Make strategic decisions that align with your goals.
27,010 articlesTrade Desk beat Q4 expectations but issued softer Q1 guidance, sparking a swift market reaction as investors weigh sl...
Microvast’s Q4 2025 results trigger a sharp pullback in mvst stock down this year. A $32.5 million inventory impairme...
Raymond James just upgraded Fastly to Outperform with a $23 price target after a sharp one-day drop, pointing to AI-d...
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Chip stocks pause after a blistering run, with Intel crashing 10%, slides as investors take profits and reassess AI m...
Strategy unveiled a plan to repurchase roughly $1.5 billion of its 2029 notes, with funding options including Bitcoin...
AI optics stocks pull back after a prolonged rally, with Applied Optoelectronics slumps 10% as LUMENTUM and Coherent ...
June 2026 shifts spotlight to Tesla and BYD as margin rebound meets policy tailwinds. Here’s the latest data and what...
Keel Infrastructure surged as it secured a large convertible financing to fuel AI data centers. This article breaks d...
Investors are watching novavax (nvax) 2025 earnings closely as the company pivots its vaccine portfolio. This article...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Pulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...